# A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

> **NCT01479504** · PHASE3 · UNKNOWN · sponsor: **Guangxi Medical University** · enrollment: 2 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** nedaplatin and docetaxel
- **DRUG:** cisplatin and docetaxel
- **DRUG:** nedaplatin and docetaxel
- **DRUG:** cisplatin and docetaxel

## Key facts

- **NCT ID:** NCT01479504
- **Lead sponsor:** Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2012-11
- **Final completion:** 2017-12
- **Target enrollment:** 2 (ESTIMATED)
- **Last updated:** 2011-11-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01479504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01479504, "A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01479504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*